Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80
Published May 25, 2022 · Recall initiated: April 5, 2022
Summary
FDA records drug Class II recall D-0884-2022, published May 25, 2022 and initiated April 5, 2022. Recalling firm: Cardinal Health Inc.; Status: Completed; Reported quantity: 1 box; Lot: Lot #: D484557A, Exp: 10/25/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
What to do
Voluntary: Firm initiated · Letter
Get an email if TRULICITY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TRULICITY
- Manufacturer
- Cardinal Health Inc.
- Distributor
- NM only
- Lot
- Lot #: D484557A, Exp: 10/25/2023.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATrulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly andMay 25, 2022
- FDADOUX SOUTH PICKLES EAT WITH A SOUTHERN ACCENT BAKKAVOR CURRY CAULIFLOWER 5 GALLONMay 25, 2022
- FDAHumalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed byMay 25, 2022
- FDAMilk & Dark Chocolate Healthy Bites. Chocolate coated caramels packaged in bulk and distributed in bulk to theMay 25, 2022
- FDASirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario CanadaMay 25, 2022
- FDADriscoll's Blackberries (Fresh) 12x6 oz, 12x12 oz, 12x10 oz, 2x8x18 oz Clamshell Distributed by StrawberryMay 25, 2022
Questions about this recall
Was Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80 recalled?
Yes. FDA published recall D-0884-2022 on May 25, 2022. Reported hazard: TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TRULICITY.